Organ-on-a-chip Platforms for Studying Drug Delivery Systems

Overview

Journal J Control Release

Specialty Pharmacology

Date 2014 May 14

PMID 24818770

Citations 140

Authors

Nupura S Bhise

Joao Ribas

Vijayan Manoharan

Yu Shrike Zhang

Alessandro Polini

Solange Massa

Mehmet R Dokmeci

Ali Khademhosseini

Affiliations

Soon will be listed here.

Abstract

Novel microfluidic tools allow new ways to manufacture and test drug delivery systems. Organ-on-a-chip systems - microscale recapitulations of complex organ functions - promise to improve the drug development pipeline. This review highlights the importance of integrating microfluidic networks with 3D tissue engineered models to create organ-on-a-chip platforms, able to meet the demand of creating robust preclinical screening models. Specific examples are cited to demonstrate the use of these systems for studying the performance of drug delivery vectors and thereby reduce the discrepancies between their performance at preclinical and clinical trials. We also highlight the future directions that need to be pursued by the research community for these proof-of-concept studies to achieve the goal of accelerating clinical translation of drug delivery nanoparticles.

Citing Articles

Microfluidic 3D cell culture: potential application of collagen hydrogels with an optimal dose of bioactive glasses.

Ghobadi F, Saadatmand M, Simorgh S, Brouki Milan P Sci Rep. 2025; 15(1):569.

PMID: 39747624 PMC: 11696724. DOI: 10.1038/s41598-024-84346-8.

Overcoming challenges in the design of drug delivery systems targeting the central nervous system.

Almutary A, Chauhan P, Baldaniya L, Menon S, Kumar M, Chaturvedi B Nanomedicine (Lond). 2024; 20(1):5-8.

PMID: 39564781 PMC: 11703128. DOI: 10.1080/17435889.2024.2421157.

Cancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling.

Nejati B, Shahhosseini R, Hajiabbasi M, Ardabili N, Baktash K, Alivirdiloo V Med Biol Eng Comput. 2024; 63(2):321-337.

PMID: 39400856 PMC: 11750902. DOI: 10.1007/s11517-024-03199-5.

Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.

Jucaud V Antibodies (Basel). 2024; 13(3).

PMID: 39189232 PMC: 11348167. DOI: 10.3390/antib13030061.

Enthesitis on Chip - A Model for Studying Acute and Chronic Inflammation of the Enthesis and its Pharmacological Treatment.

Giacomini F, Rho H, Eischen-Loges M, Tahmasebi Birgani Z, van Blitterswijk C, van Griensven M Adv Healthc Mater. 2024; 13(31):e2401815.

PMID: 39188199 PMC: 11650547. DOI: 10.1002/adhm.202401815.

References

Wilkening S, Stahl F, Bader A . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003; 31(8):1035-42. DOI: 10.1124/dmd.31.8.1035. View

Feng X, Du W, Luo Q, Liu B . Microfluidic chip: next-generation platform for systems biology. Anal Chim Acta. 2009; 650(1):83-97. DOI: 10.1016/j.aca.2009.04.051. View

Naeye B, Deschout H, Caveliers V, Descamps B, Braeckmans K, Vanhove C . In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials. 2012; 34(9):2350-8. DOI: 10.1016/j.biomaterials.2012.11.058. View

Kumar Mahto S, Tenenbaum-Katan J, Sznitman J . Respiratory physiology on a chip. Scientifica (Cairo). 2013; 2012:364054. PMC: 3820443. DOI: 10.6064/2012/364054. View

Discher D, Janmey P, Wang Y . Tissue cells feel and respond to the stiffness of their substrate. Science. 2005; 310(5751):1139-43. DOI: 10.1126/science.1116995. View

Tostoes R, Leite S, Serra M, Jensen J, Bjorquist P, Carrondo M . Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology. 2011; 55(4):1227-36. DOI: 10.1002/hep.24760. View

Dubessy C, Merlin J, Marchal C, Guillemin F . Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol. 2000; 36(2-3):179-92. DOI: 10.1016/s1040-8428(00)00085-8. View

Annabi N, Selimovic S, Acevedo Cox J, Ribas J, Bakooshli M, Heintze D . Hydrogel-coated microfluidic channels for cardiomyocyte culture. Lab Chip. 2013; 13(18):3569-77. PMC: 3744594. DOI: 10.1039/c3lc50252j. View

Pernia Leal M, Torti A, Riedinger A, La Fleur R, Petti D, Cingolani R . Controlled release of doxorubicin loaded within magnetic thermo-responsive nanocarriers under magnetic and thermal actuation in a microfluidic channel. ACS Nano. 2012; 6(12):10535-45. DOI: 10.1021/nn3028425. View

10.

Huebsch N, Arany P, Mao A, Shvartsman D, Ali O, Bencherif S . Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater. 2010; 9(6):518-26. PMC: 2919753. DOI: 10.1038/nmat2732. View

11.

Nawy T . Receptive cells feel the squeeze. Nat Methods. 2013; 10(3):198. DOI: 10.1038/nmeth.2395. View

12.

Tzeng S, Higgins L, Pomper M, Green J . Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic.... J Biomed Mater Res A. 2013; 101(7):1837-45. PMC: 3915782. DOI: 10.1002/jbm.a.34616. View

13.

Gurski L, Jha A, Zhang C, Jia X, Farach-Carson M . Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials. 2009; 30(30):6076-85. PMC: 2782556. DOI: 10.1016/j.biomaterials.2009.07.054. View

14.

Lamberti G, Tang Y, Prabhakarpandian B, Wang Y, Pant K, Kiani M . Adhesive interaction of functionalized particles and endothelium in idealized microvascular networks. Microvasc Res. 2013; 89:107-14. DOI: 10.1016/j.mvr.2013.03.007. View

15.

Leite S, Wilk-Zasadna I, Zaldivar J, Airola E, Reis-Fernandes M, Mennecozzi M . Three-dimensional HepaRG model as an attractive tool for toxicity testing. Toxicol Sci. 2012; 130(1):106-16. DOI: 10.1093/toxsci/kfs232. View

16.

Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J . Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater. 2012; 11(8):734-41. PMC: 3405191. DOI: 10.1038/nmat3361. View

17.

Zarogouldis P, Karamanos N, Porpodis K, Domvri K, Huang H, Hohenforst-Schimdt W . Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology. Int J Mol Sci. 2012; 13(9):10828-10862. PMC: 3472716. DOI: 10.3390/ijms130910828. View

18.

Wu L, Di Carlo D, Lee L . Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices. 2007; 10(2):197-202. DOI: 10.1007/s10544-007-9125-8. View

19.

Kim M, Rhee K . Computational analysis of nanoparticle adhesion to endothelium: effects of kinetic rate constants and wall shear rates. Med Biol Eng Comput. 2011; 49(7):733-41. DOI: 10.1007/s11517-011-0735-1. View

20.

Kievit F, Florczyk S, Leung M, Veiseh O, Park J, Disis M . Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials. 2010; 31(22):5903-10. PMC: 2883048. DOI: 10.1016/j.biomaterials.2010.03.062. View